Highland Capital Management Has Trimmed Cisco Systems (CSCO) Position By $496,221; OSIRIS THERAPEUTICS NEW (OSIR) Shorts Lowered By 0.85%

Highland Capital Management Llc decreased Cisco Systems Inc (CSCO) stake by 2.59% reported in 2017Q3 SEC filing. Highland Capital Management Llc sold 15,037 shares as Cisco Systems Inc (CSCO)’s stock declined 7.50%. The Highland Capital Management Llc holds 566,113 shares with $19.04 million value, down from 581,150 last quarter. Cisco Systems Inc now has $193.64 billion valuation. The stock increased 0.80% or $0.31 during the last trading session, reaching $39.17. About 29.54 million shares traded or 54.42% up from the average. Cisco Systems, Inc. (NASDAQ:CSCO) has risen 13.20% since January 4, 2017 and is uptrending. It has underperformed by 3.50% the S&P500.

OSIRIS THERAPEUTICS NEW (OTCMKTS:OSIR) had a decrease of 0.85% in short interest. OSIR’s SI was 418,600 shares in January as released by FINRA. Its down 0.85% from 422,200 shares previously. With 42,300 avg volume, 10 days are for OSIRIS THERAPEUTICS NEW (OTCMKTS:OSIR)’s short sellers to cover OSIR’s short positions. It closed at $6.15 lastly. It is down 0.00% since January 4, 2017 and is . It has underperformed by 16.70% the S&P500.

Investors sentiment decreased to 0 in 2017 Q3. Its down 0.25, from 0.25 in 2017Q2. It dropped, as 1 investors sold Osiris Therapeutics, Inc. shares while 1 reduced holdings. 0 funds opened positions while 0 raised stakes. 92,362 shares or 4.68% less from 96,898 shares in 2017Q2 were reported. Eqis Cap stated it has 0.02% of its portfolio in Osiris Therapeutics, Inc. (OTCMKTS:OSIR). Pub Employees Retirement Association Of Colorado stated it has 0% in Osiris Therapeutics, Inc. (OTCMKTS:OSIR).

Osiris Therapeutics, Inc. researches, develops, makes, markets, and distributes regenerative medicine products in the United States. The company has market cap of $212.33 million. The Company’s products include Grafix, a cryopreserved placental membrane for treating hard-to-treat acute and chronic wounds, venous leg ulcers, and burns; BIO4, a bone allograft for use in all surgical applications, including spine, trauma, extremity, cranial, and foot and ankle surgery; and Cartiform, a viable chondral allograft that promotes articular cartilage repair to treat focal chondral defects. It has a 146.43 P/E ratio. It markets and distributes its products directly to hospitals, clinics, and physician offices as well as through agents and distributors.

Analysts await Cisco Systems, Inc. (NASDAQ:CSCO) to report earnings on February, 21. They expect $0.53 EPS, 0.00% or $0.00 from last year’s $0.53 per share. CSCO’s profit will be $2.62B for 18.48 P/E if the $0.53 EPS becomes a reality. After $0.55 actual EPS reported by Cisco Systems, Inc. for the previous quarter, Wall Street now forecasts -3.64% negative EPS growth.

Investors sentiment decreased to 1.02 in 2017 Q3. Its down 0.16, from 1.18 in 2017Q2. It worsened, as 74 investors sold CSCO shares while 637 reduced holdings. 107 funds opened positions while 619 raised stakes. 3.60 billion shares or 0.03% more from 3.60 billion shares in 2017Q2 were reported. Cap Planning Advsr Ltd Liability Company holds 0.58% of its portfolio in Cisco Systems, Inc. (NASDAQ:CSCO) for 44,188 shares. Accuvest Advsr has 0% invested in Cisco Systems, Inc. (NASDAQ:CSCO). Huntington Bancorporation has invested 0.98% in Cisco Systems, Inc. (NASDAQ:CSCO). Miles Cap reported 9,581 shares. Oarsman Cap Inc owns 118,145 shares or 1.68% of their US portfolio. Moreover, Covington Incorporated has 1.51% invested in Cisco Systems, Inc. (NASDAQ:CSCO) for 119,089 shares. Avalon Advsr Limited Liability Co accumulated 1.44M shares or 1.54% of the stock. Hollencrest Secs Limited Liability holds 0.47% or 101,371 shares in its portfolio. Burgundy Asset Mgmt Ltd has invested 2.53% of its portfolio in Cisco Systems, Inc. (NASDAQ:CSCO). Salem Investment Counselors accumulated 362,036 shares. Sawgrass Asset Mngmt Limited Liability Company invested in 0.13% or 80,874 shares. Deprince Race & Zollo holds 0.54% of its portfolio in Cisco Systems, Inc. (NASDAQ:CSCO) for 709,254 shares. Boyar Asset Mgmt reported 56,701 shares or 1.42% of all its holdings. Principal Finance Group Inc Incorporated reported 11.99 million shares or 0.39% of all its holdings. 63,769 are owned by Argi Serv Limited Com.

Among 37 analysts covering Cisco Systems Inc. (NASDAQ:CSCO), 23 have Buy rating, 0 Sell and 14 Hold. Therefore 62% are positive. Cisco Systems Inc. had 132 analyst reports since August 4, 2015 according to SRatingsIntel. Jefferies maintained the shares of CSCO in report on Thursday, August 13 with “Hold” rating. UBS maintained the shares of CSCO in report on Thursday, February 11 with “Buy” rating. The firm has “Buy” rating by Jefferies given on Friday, May 26. JP Morgan upgraded the stock to “Neutral” rating in Wednesday, April 6 report. On Friday, September 23 the stock rating was maintained by Raymond James with “Outperform”. As per Friday, October 6, the company rating was maintained by Jefferies. The firm has “Buy” rating given on Thursday, June 29 by Robert W. Baird. The firm has “Underperform” rating given on Thursday, May 19 by Credit Suisse. Needham maintained Cisco Systems, Inc. (NASDAQ:CSCO) on Monday, September 18 with “Hold” rating. The firm has “Buy” rating given on Thursday, August 18 by Drexel Hamilton.

Since August 23, 2017, it had 0 insider buys, and 7 sales for $23.51 million activity. $3.89 million worth of stock was sold by Robbins Charles on Monday, September 11. Shares for $821,900 were sold by BHATT PRAT. The insider Walker Karen sold 23,110 shares worth $740,883. 15,230 shares were sold by MCGEARY RODERICK C, worth $578,740 on Thursday, December 14. $7.59M worth of stock was sold by BARTZ CAROL on Thursday, December 14. CHAMBERS JOHN T had sold 250,000 shares worth $7.79 million. CHANDLER MARK D also sold $2.11 million worth of Cisco Systems, Inc. (NASDAQ:CSCO) on Monday, September 18.

Highland Capital Management Llc increased Core S&P 500 (IVV) stake by 5,117 shares to 103,237 valued at $26.11 million in 2017Q3. It also upped Abbvie Inc (NYSE:ABBV) stake by 9,769 shares and now owns 24,979 shares. Dxc Technology Co was raised too.